Search results
Results from the WOW.Com Content Network
Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. [3] Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. [4] [5]
This is a list of companies listed on the National Stock Exchange of India (NSE). Contents !–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z !–9 Symbol ...
The Pharmaceutical industry in Gujarat ranks number one in India with a 33% share in drug manufacturing and a 28% share in drug ... Cipla Ltd., Aarti Drugs Ltd., IPCA ...
The producer price index released a day earlier on January 14 reported a modest 0.3% increase in wholesale prices in December, rising 3.3% year over year, up from 3% in November.
In 2014, Cipla acquired control of the company, and the company changed its name to Cipla Quality Chemical Industries Limited (CiplaQCIL). In 2016, the company was converted to a public company. Two years later, in 2018, the company listed on the Uganda Securities Exchange, offering shares to individual and institutional investors in an Initial ...
Yes, going plant-based can benefit blood sugar management. But my experience revealed both challenges and triumphs!
Over the course of two days, the BSE SENSEX in India dropped from 19,013 on Monday morning to 16,730 by Tuesday evening or a two-day fall of 13.9%. [66] Less than a month later, on 11 February 2008, the SENSEX lost 833.98 points, when Reliance Power fell below its IPO price in its debut trade after a high-profile public offer. [32]
Kadary Richmond hit a free-throw line jumper with 3 seconds left as No. 15 St. John's held off a strong second-half rally by Providence in a 68-66 win on Saturday in New York.